NovaRx Gets $2.2M SBIR

San Diego-based NovaRx announced that it has received a $2.2M SBIR grant from the National Institutes of Health (NIH). The grant will be applied over the next four years to the company's therapeutic vaccine for treating brain cancer. The company also announced that it is seeking further private investment to help the company bring its vaccines to market.